DBTX - Decibel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Decibel Therapeutics's activity chart (see below) currently has 18 price targets and 19 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from BAIRD on 10-Aug-2023. First documented stock forecast 09-Mar-2021.

Best performing analysts who are covering DBTX - Decibel Therapeutics:

Mani Foroohar Joseph Pantginis Jack Allen Matthew Luchini Gena Wang Neena Bitritto-Garg

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Oct-2021

$5.25

$0.34 (6.92%)

3 years 30 days ago
(10-Aug-2023)

0/2 (0%)

$0.09 (1.74%)

Hold Since 09-Aug-2023

$23

3 years 1 months 1 days ago
(09-Aug-2023)

0/1 (0%)

$15.49 (206.26%)

Hold Since 15-Mar-2023

$2

$-2.91 (-59.27%)

3 years 5 months 25 days ago
(15-Mar-2023)

0/5 (0%)

$-1.51 (-43.02%)

Buy Since 09-Mar-2021

$10

$5.09 (103.67%)

3 years 9 months 30 days ago
(10-Nov-2022)

0/2 (0%)

$6.84 (216.46%)

Buy Since 09-Mar-2021

$7

$2.09 (42.57%)

$30

4 years 5 months 19 days ago
(21-Mar-2022)

0/2 (0%)

$3.97 (131.02%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on DBTX (Decibel Therapeutics)?

Which analyst has the most public recommendations on DBTX (Decibel Therapeutics)?

has 0 price targets and 0 ratings on DBTX

Which analyst is the currently most bullish on DBTX (Decibel Therapeutics)?

Matthew Luchini with the highest potential upside of $19.09

Which analyst is the currently most reserved on DBTX (Decibel Therapeutics)?

Mani Foroohar with the lowest potential downside of -$2.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?